U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146854) titled 'EndoForce Post Approval Study' on Aug. 21.
Brief Summary: The goal of this observational study is to collect long-term safety and performance data for the use of the EndoForce System for connecting a hemodialysis graft to a vein in patients with End Stage Renal Disease. This is not an experimental procedure or an experimental therapy. This means that the study device has been approved by the FDA.
Study Start Date: Nov., 2025
Study Type: OBSERVATIONAL
Condition:
End Stage Renal Disease (ESRD)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Phraxis, Inc.
Published by HT Digital Content Services with permission from Health Daily...